Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 12, Pages 1499
Publisher
MDPI AG
Online
2021-12-20
DOI
10.3390/vaccines9121499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
- (2021) Zahra Khoshkam et al. Journal of Advanced Research
- Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
- (2021) Héloïse Flament et al. NATURE IMMUNOLOGY
- Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
- (2021) Chadi M. Saad-Roy et al. SCIENCE
- Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
- (2021) Janeri Fröberg et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The who international standard for covid-19 serological tests: towards harmonization of anti-spike assays
- (2021) Maria Infantino et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
- (2021) Janeri Fröberg et al. Nature Communications
- Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
- (2021) Giuseppe Lippi et al. Diagnostics
- Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
- (2021) Jun-Gyu Park et al. iScience
- Manifestaciones otorrinolaringológicas en pacientes con COVID-19
- (2021) Bryan Andrés Orellana Tapia CIMEL Ciencia e Investigacion Medica Estudiantil Latinoamericana
- Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
- (2021) Antonio Cristiano et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
- (2021) Letian Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
- (2021) Eva Piano Mortari et al. Cells
- An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
- (2020) Shibo Jiang et al. Emerging Microbes & Infections
- The role of IgA in COVID-19
- (2020) Yin Xia Chao et al. BRAIN BEHAVIOR AND IMMUNITY
- Serum IgA, IgM, and IgG responses in COVID-19
- (2020) Huan Ma et al. Cellular & Molecular Immunology
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Closing the Serological Gap in the Diagnostic Testing for COVID‐19: The Value of Anti‐SARS‐CoV‐2 IgA Antibodies
- (2020) Maria Infantino et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 and the Immune System
- (2020) J PACES et al. PHYSIOLOGICAL RESEARCH
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- (2020) Yanqun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
- (2020) Nora Pisanic et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
- (2020) Subodh Kumar Samrat et al. VIRUS RESEARCH
- Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease
- (2020) Aldo Roda et al. BIOSENSORS & BIOELECTRONICS
- COVID-19
- (2020) Naveen L. Pereira et al. MAYO CLINIC PROCEEDINGS
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
- Humoral Responses and Serological Assays in SARS-CoV-2 Infections
- (2020) Yannick Galipeau et al. Frontiers in Immunology
- Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
- (2020) Carlo Cervia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses
- (2016) John D. Clements et al. Clinical and Vaccine Immunology
- Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults
- (2015) Bindiya Bagga et al. JOURNAL OF INFECTIOUS DISEASES
- Secretory immunity with special reference to the oral cavity
- (2013) Per Brandtzaeg Journal of Oral Microbiology
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started